Sacituzumab |
Catalog No.GC65538 |
Sacituzumab은 항영양막 세포 표면 항원 2(anti-Trop-2)에 대한 인간화 IgG1 단일 클론 항체입니다. Sacituzumab은 전이성 삼중음성 유방암 연구의 가능성이 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1796566-95-4
Sample solution is provided at 25 µL, 10mM.
Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1].
[1]. A Bardia, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021 Sep;32(9):1148-1156.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *